INSUBCONTINENT EXCLUSIVE:
Russian clinics are bracing for a shortage of the wrinkle-reducing drug Botox amid a Western business exit over the war in Ukraine, the
Kommersant business daily reported Thursday, citing pharmaceutical researchers.Cosmetic and medical Botox imports saw a threefold drop to
NAKEM.Health clinic chain Medsi told Kommersant its supplies of Botox and other injectable drugs would last three months.Concerns were
quarter of the Russia's imports last year.Russia imported 30% of its annual supplies of Botox and other anti-wrinkle drugs in November and
imports dropped by 31% and Merz by 3% so far this year, Kommersant reported.Dwindling Botox imports coincided with a 12% year-on-year
wrinkle-reduction drugs, which scaled up production by almost 70% to 105,000 units this year, in case of serious supply disruptions or price
hikes.Medsi told Kommersant that prices have risen for domestic injectable drugs.
